Navin Fluorine Share Price: Shares of specialty chemical company Naveen Fluorine rose sharply to record high today. The company’s profit had increased more than two and a half times in the September quarter. Due to the explosive business results, investors rushed to buy its shares and it gained rocket speed. It jumped more than 15% on investor enthusiasm, its biggest intra-day gain since March 2020. Currently on BSE it reached ₹ 5689.60 with a gain of 14.34%. In intra-day it had reached a record high of ₹ 5747.95 with a jump of 15.51%. Last year, on December 31, 2024, it was at a one-year low of 3183.20. Now talking further, out of 29 analysts covering it, 20 have given it a buy rating, four have given hold and five have given sell rating.
How was the September quarter for Navin Fluorine?
In the second quarter of the current financial year 2026 July-September 2026, Naveen Fluorine’s consolidated profit increased by 152.2% to ₹ 148.4 crore and revenue jumped by 46.3% to ₹ 758.4 crore. Talking about the operating level, the company’s operating profit more than doubled and the operating margin increased by 12 percentage points from 20.8% to 32.4%. The company’s revenue from High Performance Products (HPP) business grew 38% to ₹404 crore, while the specialty business jumped 35% to ₹219 crore. The company’s CDMO business also almost doubled on an annual basis to reach ₹134 crore.
The company said in the earnings call that it expects margins to remain around 30% in FY 2026 and a similar situation may prevail in the next FY 2027. The company expects that the second half of this financial year 2026 will be better for the company and the revenue of CDMO business can reach $100 million in financial year 2027.
How is the trend of brokerages?
Brokerage firm UBS Naveen Florin has increased the target price to ₹ 5,900 with a buy rating. UBS believes that Naveen Fluorine’s focus on late-stage molecules and the ongoing validation process with multiple companies will support sustainable growth of the CDMO business in the medium-term.
Another brokerage firm Jefferies has given buy rating to Naveen Fluorine with a target price of ₹6,635. Jefferies has raised Naveen Fluorine’s FY2026 operating profit forecast by 13% and FY2027 operating profit forecast by 14%. Jefferies expects its EPS to grow at a compound annual growth rate (CAGR) of 44% between FY 2025-28.
Disclaimer: The advice or opinions expressed on Moneycontrol.com are the personal views of the expert/brokerage firm. The website or management is not responsible for this. Moneycontrol advises users to always seek the advice of a certified expert before taking any investment decision.